By City News Service
UCLA and UC Irvine are among five University of California medical campuses that will share a $12 million grant from the National Heart, Lung and Blood Institute, it was announced Friday.
The award recognizes the UC system's potential to convert leading-edge discoveries into products that benefit patients.
The research, to be based at UCLA, will have four goals:
- Engage UC heart, lung and blood disease innovators in entrepreneurial pursuits through education, training and mentorship programs.
- Solicit and select technologies with high commercial potential that address unmet medical needs or significant scientific opportunity.
- Tailor promising technologies to meet industry requirements to help their development into commercial products that improve patient care and health.
- Create a high-performing infrastructure that will serve as a model to academic research centers.
Other UC medical campuses participating in the research are in Davis, San Diego and San Francisco.